Company Overview of Zyngenia, Inc.
Zyngenia, Inc., a biopharmaceutical company, engages in the development of multi-specific antibody-based drugs in the United States. It focuses on the development of therapies for various cancers and autoimmune disorders. The company was incorporated in 2008 and is based in Gaithersburg, Maryland.
21 Firstfield Road
Gaithersburg, MD 20878
Founded in 2008
Key Executives for Zyngenia, Inc.
Zyngenia, Inc. Key Developments
Similar Private Companies By Industry
|Bio-multimin, Inc.||United States|
|GMP Laboratories of America, Inc.||United States|
|Clarus Therapeutics, Inc.||United States|
|Seroyal USA, Inc.||United States|
|Physician Choice, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Deerfield, IL | Takeda Pharmaceuticals North AmericaPosted: Apr 15
- Washington, DC | PwCPosted: Aug 20
- Florham Park, NJ | PwCPosted: Aug 20
- Arlington Heights, IL | InventivPosted: Apr 17
Sponsored Financial Commentaries
To contact Zyngenia, Inc., please visit www.zyngenia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.